Inflammatory morphea in the context of Raynaud phenomenon. Even in the absence of initial symptoms to support systemic disease, patients presenting with morphea in the setting of Raynaud phenomenon or anti-centromere antibodies deserve close surveillance for the possibility of CREST syndrome and systemic sclerosis. Naheed Abbasi MD MPH. Dermatology Online Journal. October 2008. (Also see: Raynaud's and Morphea)
This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
1 reply to this topic
Posted 16 February 2009 - 03:23 PM